Latest news
What Does Merck (MRK) Lose From Ending Its Late Stage Lung Cancer Trial? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 11:37:53 GMTPfizer and Merck Set to Report Quarterly Earnings Amidst Declining Estimates - Intellectia AIIntellectia AI · Sat, 08 Aug 2026 10:35:58 GMTMerck KGaA (XTRA:MRK) Stock Run Meets Profit Margin Drift - simplywall.stsimplywall.st · Sat, 08 Aug 2026 00:42:34 GMTMerck & Co., Inc. 2026: Revenue $16.61B, EPS ($0.54) — 10-Q Summary - TradingViewTradingView · Fri, 07 Aug 2026 20:23:58 GMTMerck (MRK) Could Be 3% Undervalued On Raised Outlook And Key Drug Approvals - Yahoo Finance SingaporeYahoo Finance Singapore · Fri, 07 Aug 2026 11:14:16 GMTAfter Q2 Earnings, Is Pfizer or Merck the Smarter Dividend Play? - 247wallst.com247wallst.com · Thu, 06 Aug 2026 16:00:23 GMTHow Stronger 2026 Guidance And New Drug Indications At Merck (MRK) Has Changed Its Investment Story - simplywall.stsimplywall.st · Thu, 06 Aug 2026 13:35:36 GMTMerck Lifts Revenue View, Halves Profit Forecast - communitynews.orgcommunitynews.org · Thu, 06 Aug 2026 12:18:08 GMT